24.04.2022, 844 Zeichen

Valneva: Albumedix is expanding its existing collaboration with Austrian/French  Valneva, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need.  This announcement comes on the back of the recent approval of Valneva´s inactivated COVID-19 vaccine (VLA2001) by MHRA, for which Valneva signed an agreement in November 2021 with the European Commission to supply up to 60 million doses over two years, as well as announcing an advance purchase agreement with the Kingdom of Bahrain in December 2021 for the supply of one million doses. Albumedix Recombumin rHA is an essential component in VLA2001, used in the manufacturing process and final formulation of the vaccine.
Valneva: weekly performance: -8.08%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (18/04/2022)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #1198: ATX schwächer, guter Tag für Semperit, 2. Versuch vom Sommerloch und eine klare Präferenz bei Addiko Bank

Bildnachweis

Aktien auf dem Radar:Porr, Kapsch TrafficCom, Flughafen Wien, EuroTeleSites AG, RHI Magnesita, Austriacard Holdings AG, OMV, Telekom Austria, voestalpine, Verbund, SBO, Lenzing, Strabag, FACC, Bawag, Andritz, Addiko Bank, Frequentis, RBI, Semperit, BKS Bank Stamm, Marinomed Biotech, Amag, CPI Europe AG, Österreichische Post, UBM, IBM, Goldman Sachs, Commerzbank, Fresenius Medical Care, Mercedes-Benz Group.

---